Potential Subtherapeutic Linezolid and Meropenem Antibiotic Concentrations in a Patient With Severe Burns and Sepsis
- 1 January 2010
- journal article
- case report
- Published by Oxford University Press (OUP) in Journal of Burn Care & Research
- Vol. 31 (1), 207-209
- https://doi.org/10.1097/bcr.0b013e3181c89ee3
Abstract
Altered pharmacokinetics in patients with major burns may result in serum antibiotic concentrations below those required to be effective against the common pathogens encountered in burns patients. The major changes in the fluid volumes of key body compartments, which occur with a large burn, may increase the apparent volume of distribution of a drug, thereby lowering its concentration when a standard dose is given. In addition, the observed increase in renal blood flow reported in burns patients, because of the change in cardiac output, may result in a higher drug clearance and a shorter elimination half-life. As a consequence, studies have recommended higher doses or more frequent dosing or both for some antibiotics in patients with major burns, but data are lacking for many of the antibiotics reserved for treatment of life-threatening infections. The authors measured serum concentrations of two antibiotics, linezolid and meropenem, in an immunosuppressed patient who presented with a severe burn to determine whether therapeutic concentrations were achieved, thereby improving the likelihood of infection control.Keywords
This publication has 7 references indexed in Scilit:
- Pharmacokinetics/pharmacodynamics of antibacterials in the Intensive Care Unit: setting appropriate dosing regimensInternational Journal of Antimicrobial Agents, 2008
- Linezolid pharmacokinetic/pharmacodynamic profile in critically ill septic patients: intermittent versus continuous infusionInternational Journal of Antimicrobial Agents, 2008
- Antimicrobial Resistance: Pharmacokinetics‐Pharmacodynamics of Antimicrobial Therapy: It’s Not Just for Mice AnymoreClinical Infectious Diseases, 2007
- Pharmacodynamic Activity and Efficacy of Linezolid in a Rat Model of Pneumococcal PneumoniaAntimicrobial Agents and Chemotherapy, 2002
- Pharmacokinetics of antibiotics in burn patientsJournal of Antimicrobial Chemotherapy, 1999
- State‐of‐the‐Art Clinical Article: Pharmacokinetic/Pharmacodynamic Parameters: Rationale for Antibacterial Dosing of Mice and MenClinical Infectious Diseases, 1998
- Initial Dosage Regimens of Gentamicin in Patients with BurnsJournal of Burn Care & Rehabilitation, 1991